INTRODUCTION
The mammalian redox defence system, based on GSSG and glutathione reductase (GR), is replaced in trypanosomes and Leishmania by an analogous, but distinct, system based on oxidized trypanothione (1) and trypanothione reductase (TR) [1] . Mammalian GR, an NADPH-dependent flavoenzyme, cata-NH3,,,,,OCONH CONH CONH C02-NH2 N143 CONH CONH CONH Trypanothione (1) lyses regeneration of GSH from GSSG (see eqn. 1); TR, the trypanosomal equivalent of GR, converts 1 (TSST) into the dithiol (or reduced) form, (HS)TT(SH) (eqn. The almost total mutual substrate exclusivity of these two enzymes is the basis [2] for rational design of selective inhibitors of TR in the presence of host GR. Powerful inhibition of TR, severely compromising the parasite's redox defences, may provide a drug lead. Selectivity of substrate binding for GR and TR has been probed by using substrate analogues [3, 4] , by site-directed mutagenesis [5] [6] [7] [8] and X-ray diffraction studies [9, 10] .
Trypanothione (1) is an unlikely lead for drug design. Consequently, we are interested in simplifying TR recognition requirements relative to the TSST structure and in finding replacements for the highly charged residues. We have already discovered a hydrophobic site in the region of trypanothione binding and introduced [3] a cheap, convenient new assay substrate for TR based on it.
MATERUILS AND METHODS
Trypanothione reductase from Trypanosoma cruzi was isolated by means of overexpression. The gene coding for T. cruzi (Brazilian Silvio strain, clone X1O/1) was amplified by the PCR from genomic DNA using primers designed for the N-terminal regions ofthe protein (A. Borges & A. H. Fairlamb, unpublished work; details available from A. B. on request; [11] [3] . Enzyme activity was measured at 25°C in 0.02 MHepes buffer, pH 7.25, containing 0.15 M-KCI, 1 mM-EDTA and 0.1 mm-NADPH [13] with an enzyme concentration of 0.3 jug ml-'. Human erythrocyte GR was assayed as described [14] in the presence of 1 mM-GSSG and 0. Vol. 286 weighting) least-squares non-linear regression analysis of the data using the equation for linear competitive inhibition:
Potential inhibitor design was guided by a computer-graphics model of TR, constructed by modification of the published coordinates of human erythrocyte GR [9] using the QUANTA software on a Silicon Graphics 240D workstation.
RESULTS AND DISCUSSION
The detailed binding of GSSG to human erythrocyte GR has been described in detail in an excellent study of substrate recognition [5, 15] . Of particular interest for substrate-specificity distinction between GR and TR is the hydrophobic wall formed by Leu-17, Trp-21, Tyr-110, Met-113 and Phe-114 of TR [5] , which corresponds to a polar region in GR, provided by Leu-33, Arg-37, Tyr-114, Asn-117 and Leu-118 of GR [15] and is responsible for binding the glycyl carboxylate groups of GSSG. As inhibitor target molecules were built by docking fragments into this region, it became evident from computer analysis that some known phenothiazine and tricyclic antidepressant drugs could be accommodated at this hydrophobic wall site, and comparison with the GR structure predicted them to be selective inhibitors of TR. Subsequent assay against recombinant TR confirmed this. Of 30 compounds screened, three typical neuroleptics/antidepressants [namely clomipramine (2) (3) and trifluoperazine (4); Table 1 ] studied in detail were found to be simple linear competitive inhibitors of TR with either trypanothione or N-benzyloxycarbonyl-L-cysteinylglycyl 3-dimethylaminopropylamide disulphide [3] as varying substrate (Table 1) . Under comparable conditions (Table 1) these compounds did not inhibit human erythrocyte or yeast GR. Fig. 1 shows a typical example of the competitive inhibition. The simplest explanation of the results is that such drugs inhibit TR by occupying at least part of the TSST-binding region and are therefore selective, since GR does not recognize TSST. The drug mepacrine (quinacrine) has been shown to inhibit TR, but not GR, but this was discussed in terms of the resemblance of its side chain to a polyamine [16] . Molecular modelling indicates that such molecules could bind with the tricyclic moiety lodged into the hydrophobic wall region and the aminopropyl side chain (Fig. 2a) extending backwards in the general direction of the active site. Binding is reasonably tight and affected by the fine structure of the central ring and/or substituents ( Table 1) . Fig. 2(b) shows the active site from the same orientation as Fig. 2(a) with trypanothione docked, putting the spermidine cross-link along the hydrophobic wall. Analogues of 2-4, such as chlorpromazine [17] (which also inhibits TR; results not shown), have been reported to have anti-trypanosomal activity, ascribed to interference with microtubule assembly [18] , and anti-leishmanial activity, ascribed to membrane disruption [19] , especially of the proton-based electrochemical gradient [20] . Other amphiphilic cationic drugs have been screened for prevention of transmission ofChagas' disease by blood transfusion [21] . Among the most potent were tricyclic antidepressants. Our site of TR (a) Representation of clomipramine (heavy line) docked into the active site of TR (modelled using the co-ordinates of human erythrocyte GR [9] ). The hydrophobic wall formed by Ml 13 (Met-113), F114 (Phe-114), W21 (Trp-21) and L17 (Leu-17) is closely juxtaposed to the tricyclic region of the inhibitor. The dimethylamino group of the side chain of clomipramine is shown protonated and is within salt-link distance of the carboxylate ion of the side chain of E467' (Glu-467). The conformation of clomipramine was based on the X-ray-diffraction co-ordinates of clomipramine with suitable adjustment of the side chain [22] . Energy minimization of the enzyme-bound-ligand complex provided a structure with the tricyclic system twisted about the central ring axis through nitrogen in the opposite sense of this crystal-structure-derived conformation. In the opposite twist-sense interaction with the aromatic face of W21 looks better. (b) Docked representation of trypanothione bound to the active site of modelled TR from the same orientation as clomipramine shown in (a) with the spermidine region bound near the hydrophobic wall (M1 13, F1 14, W21 and L17). The co-ordinates of bound trypanothione were determined from those of GSSG bound to GR [9, 11] .
registered for use in man. Detailed structure-function studies are needed, as are detailed binding studies using X-ray diffraction and other approaches.
